BISTTRYOct 9, 18:19Live
TRILC Balance Sheet and Financial StatementsTürk İlaç ve Serum Sanayi A.Ş.
Watchlist MarketChemicals, Petroleum, Rubber and Plastics
0.94−0.05 (−5.05%)
- Volume
- TRY 3.6M
- Day range
- 0.92 – 0.98
- Previous close
- 0.99
- Market cap
- TRY 974.8M
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for TRILC is 2026/3. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Türk İlaç ve Serum Sanayi A.Ş. (TRILC), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/3 | 1.4B | 262.7M | 207.6M |
| 2025/12 | 1.8B | 681.6M | −190.5M |
| 2025/9 | 1.3B | 293.3M | 76.2M |
| 2025/6 | 572.2M | 127.7M | −177.1M |
| 2025/3 | 841M | 110.4M | −393.8M |
Frequently Asked Questions
How much profit did TRILC report in its latest statements?
In the latest period (2026/3) TRILC reported a net profit of TRY 207.6M, sales of TRY 1.4B and EBITDA of TRY 262.7M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.